<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Amara, Khaled</dc:creator>
  <dc:creator>Steen, Johanna</dc:creator>
  <dc:creator>Murray, Fiona</dc:creator>
  <dc:creator>Morbach, Henner</dc:creator>
  <dc:creator>Fernandez-Rodriguez, Blanca M.</dc:creator>
  <dc:creator>Joshua, Vijay</dc:creator>
  <dc:creator>Engström, Marianne</dc:creator>
  <dc:creator>Snir, Omri</dc:creator>
  <dc:creator>Israelsson, Lena</dc:creator>
  <dc:creator>Catrina, Anca I.</dc:creator>
  <dc:creator>Wardemann, Hedda</dc:creator>
  <dc:creator>Corti, Davide</dc:creator>
  <dc:creator>Meffre, Eric</dc:creator>
  <dc:creator>Klareskog, Lars</dc:creator>
  <dc:creator>Malmström, Vivianne</dc:creator>
  <dc:date>2013-02-25</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Antibodies targeting citrullinated proteins (ACPAs [anticitrullinated protein antibodies]) are  commonly found in patients with rheumatoid arthritis (RA), strongly associate with distinct  HLA-DR alleles, and predict a more aggressive disease course as compared with  seronegative patients. Still, many features of these antibodies, including their site of production  and the extent of MHC class II–driven T cell help, remain unclarified. To address these  questions, we have used a single B cell–based cloning technology to isolate and express  immunoglobulin (Ig) genes from joint-derived B cells of active RA patients. We found ∼25% of  synovial IgG-expressing B cells to be specific for citrullinated autoantigens in the investigated  ACPA+ RA patients, whereas such antibodies were not found in ACPA− patients. The  citrulline-reactive monoclonal antibodies did not react with the unmodified arginine peptides,  yet several reacted with more than one citrullinated antigen. A role for active antigen selection  of the citrulline-reactive synovial B cells was supported by the strong bias toward amino acid  replacement mutations in ACPA+ antibodies and by their loss of reactivity to citrullinated  autoantigens when somatic mutations were reverted to the corresponding germline  sequences.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://n2t.net/ark:/12658/srd1318861</dc:identifier>
  <dc:identifier>https://susi.usi.ch/global/documents/318861</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/318861/files/Amara_JEM_2013.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1084/jem.20121486</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1318861</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>CC BY-NC-SA</dc:rights>
  <dc:source>The journal of experimental medicine. - 2013, vol. 210, no. 3, p. 445-455</dc:source>
  <dc:subject>info:eu-repo/classification/udc/61</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
